An Open Label Phase 1 Study in Healthy Adult Female Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of [14C]-D-0502 Following Single Oral Dose Administration
Latest Information Update: 07 Apr 2023
At a glance
- Drugs Taragarestrant (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors InventisBio
Most Recent Events
- 04 Apr 2023 Status changed from active, no longer recruiting to completed.
- 19 May 2022 Planned primary completion date changed from 2 May 2022 to 2 Aug 2022.
- 03 May 2022 Status changed from recruiting to active, no longer recruiting.